Advertisement

Topics

Search Results for "Pharmac Cost Of Sativex In New Zealand"

13:12 EST 12th February 2016 | BioPortfolio

Matching Channels

Marginal cost

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...

CaptureSelect

BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...

CombiCult

CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Matching News

NZ’s PHARMAC consults on multiple sclerosis treatments

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on proposals to list two…

NZ’s PHARMAC to list Actelion’s PAH drug Veletri

New Zealand’s Pharmaceutical Management agency PHARMAC today announced the approval of an agreement…

PHARMAC proposal to list new respiratory products

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to relating…

Tender still important to maintain New Zealanders’ access to medicines, says PHARMAC chief

New Zealand’s Pharmaceuticals Management Agency PHARMAC’s annual tender continues to achieve its…

New Zealand decision relating to a number of respiratory products

Following a consultation last December, New Zealand’s Pharmaceutical Management Agency PHARMAC is today…

Asacol 800mg tablets approved for funding in New Zealand

New Zealand’s Pharmaceutical Management Agency, PHARMAC, has announce the approval of an agreement…

New Zealand proposal to amend the listing of some respiratory products

New Zealand’s Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to amend…

New Zealand to fund two new multiple sclerosis treatments

New Zealand’s Pharmaceutical Management Agency PHARMAC has approval proposals to fund two new treatments…

Matching PubMed Articles

Uptake of new medicines: the Pharmaceutical Management Agency of New Zealand (PHARMAC) in the international context.

New Zealand patients.

Objective The aim of the present study was to better understand the views and experiences of New Zealand patients on switching between brands of prescription medicines and on alternative funding optio...

Is cost-related non-collection of prescriptions associated with a reduction in health? Findings from a large-scale longitudinal study of New Zealand adults.

To investigate whether cost-related non-collection of prescription medication is associated with a decline in health.

HIV-associated tuberculosis in Auckland.

New Zealand has low rates of disease caused by to Mycobacterium tuberculosis (TB) and Human Immunodeficiency Virus (HIV). This study is the first to describe a New Zealand cohort of patients with HIV-...

The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)-tetrahydrocannabinol acting through CB1 receptors.

Sativex®, an equimolecular combination of Δ(9)-tetrahydrocannabinol-botanical drug substance (Δ(9)-THC-BDS) and cannabidiol-botanical drug substance (CBD-BDS), is a licensed medicine that may be pr...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement